Joan M. O’Brien

University of Pennsylvania
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (9)

Year:

2026

Year:

2025

Background Beta-Peripapillary Atrophy (beta-PPA) is an optic nerve head change associated with primary open-angle glaucoma (POAG). We evaluated demographic, ocular, and genetic risk factors for beta-PPA in individuals of African ancestry with POAG. Methods POAG cases were recruited from the Primary Open-Angle African American Glaucoma Genetics (POAAGG) study. Beta-PPA was defined as hypopigmentation with visible choroidal vessels and sclera adjacent to the optic disc. Univariable and multivariable regression models assessed risk factors for the presence and extent of beta-PPA. Results Among 3381 eyes, 969 (28.6%) had beta-PPA. Beta-PPA was associated with older age (OR = 2.90, p < 0.001) and larger vertical cup-to-disc ratio (CDR) (OR = 1.58, p = 0.007), and was less common in females (OR = 0.53, p < 0.001). Beta-PPA presence was negatively associated with grey crescent (OR = 0.47, p = 0.01), neural rim notching (OR = 0.43, p = 0.01), and cylindrical (OR = 0.55, p < 0.001) or bean pot cup shapes (OR = 0.59, p < 0.001). Larger beta-PPA area was linked to older age ( p = 0.008) and large vertical CDR ( p = 0.03), but was less likely with conus pigmentosus ( p = 0.001), deeper cup depth ( p = 0.006), higher IOP ( p = 0.005), and rounder discs ( p = 0.01). Higher polygenic risk score ( p = 0.007) and presence of the SNP rs34957764 in ROCK1P1 ( p = 0.053) were associated with beta-PPA, but the same SNP was also associated with lesser area of beta-PPA ( p = 0.03). Regions of beta-PPA correlated with greater RNFL loss ( p < 0.01). Conclusions Beta-PPA is strongly associated with older age and high CDR among individuals with POAG. These regions are vulnerable to RNFL loss.

Year:

2025

Objective To define sloping of the retina, a novel stereoscopic feature in primary open-angle glaucoma (POAG), and to evaluate its prevalence and associated risk factors in an African ancestry population. Methods and analysis Digital stereo disc images were graded for sloping by trained non-physician graders. We defined a sloping retina as one that slanted downward towards the disc margin instead of existing on the same plane as the disc margin. A ‘sloping retina’ approached the disc margin at an angle along at least one-third of the disc’s circumference. The ocular and demographic risk factors of sloping were evaluated by univariable and multivariable logistic regression models. Results The prevalence of sloping in eyes with POAG was 22.0% (95% CI 20.6% to 23.4%). In a multivariable analysis, compared with eyes without sloping, eyes with sloping were less likely to have disc haemorrhages (p=0.03) and more likely to have a tilted disc (p<0.001), larger cup-to-disc ratio ((defined as 0.7–1), p=0.002), grey crescent (p=0.02), nasalisation of the vessels (p=0.01), moderate or deep cup depth (p<0.001) and conical cup shape (p<0.001). Sloping was not associated with any demographic characteristics in the multivariable analysis. Conclusion Associated with risk factors of advanced POAG, sloping presents as a novel feature that warrants further study to determine its mechanisms of development and prevalence in other study populations. Study limitations include: large difference in the number of eyes with and without sloping, potential morphological expressions of other phenotypes posing as sloping, impact of anatomical variability on grading, inherent biases when grading stereoscopic images and absence of a control or glaucoma suspect group. Future research into this phenotype in POAG patients might determine whether sloping retina is the result of or a precursor to glaucomatous damage, leading to a better understanding of POAG.

Year:

2025

There are scarce data regarding the rate of the occurrence of primary open-angle glaucoma (POAG) and visible lamina cribrosa pores (LCPs) in the eyes of individuals with African ancestry; the potential impact of these features on disease burden remains unknown. We recruited subjects with POAG to the Primary Open-Angle African American Glaucoma Genetics (POAAGG) study. Through regression models, we evaluated the association between the presence of LCPs and various phenotypic features. In a multivariable analysis of 1187 glaucomatous eyes, LCPs were found to be more likely to be present in eyes with cup-to-disc ratios (CDR) of ≥0.9 (adjusted risk ratio (aRR) 1.11, 95%CI: 1.04–1.19, p = 0.005), eyes with cylindrical-shaped (aRR 1.22, 95%CI: 1.11–1.33) and bean pot (aRR 1.24, 95%CI: 1.13–1.36) cups versus conical cups (p < 0.0001), moderate cup depth (aRR 1.24, 95%CI: 1.06–1.46) and deep cups (aRR 1.27, 95%CI: 1.07–1.50) compared to shallow cups (p = 0.01), and the nasalization of central retinal vessels (aRR 1.33, 95%CI: 1.23–1.44), p < 0.0001). Eyes with LCPs were more likely to have a higher degree of African ancestry (q0), determined by means of SNP analysis (aRR 0.96, 95%CI: 0.93–0.99, p = 0.005 for per 0.1 increase in q0). Our large cohort of POAG cases of people with African ancestry showed that LCPs may be an important risk factor in identifying severe disease, potentially warranting closer monitoring by physicians.

Year:

2024

Genome-wide association studies (GWAS) have identified genetic links to autoimmune disorders, but lack detail on causal elements. We generated 3D genomic datasets of promoter-focused Capture-C, Hi-C, ATAC-seq, and RNA-seq across 57 human cell types integrated with GWAS of 16 autoimmune traits. These data allowed us to map disease-associated variants to their effector genes and identify impacted cell types more effectively than using 1D genomic features or eQTL approaches. Most variants implicated by 3D cis-regulatory architectures are trait-specific, while half the target genes are shared across multiple disorders and cell types, leading to enrichment of similar biological networks. This indicates complex genetic diversity converges on shared targets, yet unique pathways were identified offering avenues for targeted therapies. We pharmacologically validated squalene synthase, a cholesterol biosynthetic enzyme encoded by the FDFT1 gene implicated by our approach and eQTL in multiple sclerosis and systemic lupus erythematosus, as a novel immunomodulatory drug target controlling T cell inflammatory cytokine production and aiding B cell antibody production in a human lymphoid organoid model. These data offer a comprehensive resource for understanding gene cis-regulatory mechanisms, and the analyses shed light on how autoimmune-associated variants regulate gene expression, function, and pathology across diverse tissues and cell types.

Year:

2024

Recent genome-wide association studies (GWAS) revealed shared genetic components among substance use disorders (SUDs). However, the extent of underlying shared causal variants, effector genes, and cellular contexts, remain unclear. We integrated 3D genomic datasets (high-resolution promoter-focused Capture-C/Hi-C, ATAC-seq, RNA-seq) from 59 diverse human cell types with recent GWAS summary statistics for alcohol (AUD), tobacco (TUD), opioid (OUD), and cannabis use disorder (CanUD). Using stratified LD regression, we determined the proportion of SNP heritability attributable to features in these cell types. We observed significant enrichments ( P <0.05) in 25 cell types. Heritability reached 4.2-fold enrichment for CanUD in iPSC-derived cortical neurons and 6-fold for AUD/TUD in neural progenitors, confirming their relevance for functional exploration. Additionally, pancreatic cell types, notably insulin-secreted beta cells, showed heritability enrichment for TUD (4.8-fold) and CanUD (5.8-fold), suggesting genomic overlap with metabolic processes. Further investigation revealed significant positive genetic correlations between AUD, TUD, and CanUD with type 2 diabetes (T2D) (FDR<0.05). A multi-omic integrated assessment of T2D-SUD correlated loci revealed strong correlations between gene expression and chromatin accessibility at corresponding cis-regulatory elements and shared functional modules. Our study provides new genomic insights into SUDs and implicates specific cell types for targeted functional follow-up to pinpoint causal variant-gene mechanisms.

Year:

2024

Background: Over the last decade, studies have suggested that primary open-angle glaucoma (POAG) may be associated with cognitive impairment and dementia, as both pathologies are age-related neurodegenerative processes. It remains unclear to what extent neurodegeneration in POAG extends to other neurological functions beyond vision, such as cognition. This follow-up study examined the potential association between POAG and cognitive decline in an African ancestry population. Methods: The Telephone-Montreal Cognitive Assessment (T-MoCA) was administered to POAG cases and controls previously enrolled in the Primary Open-Angle African American Glaucoma Genetics (POAAGG) study. Cases were assessed for retinal nerve fiber layer (RNFL) thickness and for the presence of dementia via chart review. Comparisons between POAG cases and controls were performed using two-sample t-tests for the T-MoCA total score and five subsection scores, and using chi-squared tests for incidence of dementia. Current scores were compared to scores from this same cohort from 7 years prior. Results: The T-MoCA was administered to 13 cases and 20 controls. The mean ± standard deviation (SD) T-MoCA total score was 15.5 ± 4.0 in cases and 16.7 ± 3.5 in controls (p = 0.36). However, there was a borderline significant difference in the delayed recall sub-score (2.3 ± 1.6 for cases vs. 3.4 ± 1.5 for controls, p = 0.052) and a significant difference in its sub-domain, the memory index score (MIS, 9.1 ± 4.3 for cases vs. 12.1 ± 3.0 for controls, p = 0.02). There were no significant differences between cases and controls for the remaining subsections. During 7 years of follow-up, a higher incidence of dementia was noted in POAG cases (7.1% for cases vs. 0% for controls, p = 0.058). Over 7 years, there was no significant deterioration in the cognitive performance of cases versus controls, and no association was seen between RNFL thinning and cognitive impairment. Conclusions: In this small-sample follow-up study of African ancestry individuals, POAG cases demonstrated worse short-term memory and higher incidence of dementia compared to controls. Future larger studies are needed to further investigate the presence and impact of neurodegeneration in POAG.

Year:

2024

Glaucoma is the leading cause of irreversible blindness, and its pathophysiology includes neuroinflammatory changes. The present therapies for glaucoma target pressure-lowering mechanisms with limited success, making neuroinflammation a target for future interventions. This review summarizes the neuroinflammatory pathways seen in glaucoma and their interplay with stress. Glucocorticoids have been shown to activate proinflammatory glial cells, contributing to the neuroinflammation in glaucoma. Glucocorticoids have also been shown to increase the IOP directly. Stress-associated autonomic dysfunction can affect the vascular homeostasis in the retina and create oxidative stress. Diabetes, hyperglycemic-mediated endothelial damage, and vascular inflammation also play important roles in the neuroinflammation in glaucoma and diabetic retinopathy. Psychosocial stress has been implicated in an increased IOP and glaucoma outcomes. People who experience maladaptive chronic stress suffer from a condition known as allostatic load, which describes pathologic neuroendocrine dysregulation. The effects of allostatic load and chronic stress have been studied in patients affected by a lower socioeconomic status (SES) and marginalized racial identities. A lower SES is associated with higher rates of glaucoma and also affects the access to care and screening. Additionally, people of African ancestry are disproportionately affected by glaucoma for reasons that are multifactorial. In conclusion, this review explores neuroinflammation in glaucoma, highlighting opportunities for future investigation.

Year:

2024

Collaborators (16)

Struan Grant

Professor of Genetics and Pediatrics

University of Pennsylvania

UNITED STATES
View details

Rachel Kember

Research Assistant Professor

University of Pennsylvania

UNITED STATES
View details

Gui-Shuang Ying

Professor, Clinician-Educator

University of Pennsylvania

UNITED STATES
View details

Paul M Titchenell

University of Pennsylvania

UNITED STATES
View details

Laura Cook

Senior Research Fellow and Group Leader

University of Melbourne

AUSTRALIA
View details

Kurt Hankenson

University of Michigan

UNITED STATES
View details

Yadav Wagley

University of Michigan Medical School

UNITED STATES
View details

Henry Kranzler

Professor

University of Pennsylvania

UNITED STATES
View details

Babette S Zemel

Professor

Children's Hospital of Philadelphia

UNITED STATES
View details

Megan Levings

Professor

The University of British Columbia

CANADA
View details

Jaclyn Welles

Research Assistant Professor

Northeast Ohio Medical University

UNITED STATES
View details

Wenli Yang

Research Assistant Professor

University of Pennsylvania

UNITED STATES
View details

Klaus Kaestner

Professor

University of Pennsylvania

UNITED STATES
View details

Alessandra Chesi

Assistant Professor

University of Pennsylvania

UNITED STATES
View details

Andrew Wells

PROFESSOR

University of Pennsylvania

UNITED STATES
View details

Patrick Seale

Associate Professor

University of Pennsylvania

UNITED STATES
View details